CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21,240 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03656939
NCT03656939N/ACompleted

AN OBSERVATIONAL SAFETY STUDY FOR PREVENAR 13 AMONG CHINESE CHILDREN

Pfizer·observational·Posted Sep 4, 2018·Updated Aug 27, 2021

In Brief

An observational study for Seizures and 3 related conditions. Completed, enrolled 21,240 participants across 1 site.

Detailed Summary

This is an observational study based on a population-based EHR database.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 4, 2018
Enrollment StartAug 1, 2018
Primary CompletionJul 31, 2020
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 7.8 years ago